Prostate cancer imaging drug showdown ends early
Knowledge-focused
Terminated
This early-stage study aimed to compare two radioactive drugs (lutetium rhPSMA-10.1 and Pluvicto) in 17 men with advanced prostate cancer that cannot be cured. The goal was to see which drug delivers more radiation to tumors while sparing the kidneys. The study was terminated ear…
Phase: EARLY_PHASE1 • Sponsor: Blue Earth Therapeutics Ltd • Aim: Knowledge-focused
Last updated May 04, 2026 05:44 UTC